STOCKHOLDERS' EQUITY (Details Textual) (USD $)	1 Months Ended	12 Months Ended		0 Months Ended	1 Months Ended	3 Months Ended		12 Months Ended		1 Months Ended
	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Feb. 02, 2012 Financing 2012 [Member]	May 31, 2012 Financing 2012 [Member]	Mar. 31, 2013 Financing 2013 [Member]	Mar. 31, 2013 Agent Warrant [Member]	Dec. 31, 2002 Series A Preferred Stock [Member]	Apr. 30, 2012 Series A Preferred Stock [Member]	Apr. 30, 2012 Series A Preferred Stock [Member] Financing 2012 [Member]
Stockholders Equity [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities										1,522,727
Common stock, shares issued		27,119,974	22,582,938			4,495,828
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,739,132		2,247,912	61,250
Class Of Warrant Or Right Par Value Of Securities Called By Warrants Or Rights				$ 0.01
Class of Warrant or Right, Exercise Price of Warrants or Rights				1.40		2.91	3.00
Fair Value Assumptions, Expected Term				5 years 6 months		3 years 6 months	4 years 7 months 6 days
Fair Value Assumptions, Risk Free Interest Rate				0.71%		0.40%	0.85%
Gross Proceeds From Issuance Of Shares And Warrants						$ 10,800,000
Class Of Warrant Or Right Description Of Securities Called By Warrants				The 2012 Warrants cover a number of shares of common stock equal to 20% of the principal amount of the Notes purchased by each Investor, divided by $1.15.
Class Of Warrant Or Right Maturity Period Description				The 2012 Warrants have an exercise price of $1.40 per share and became exercisable on July 29, 2012 and expire on July 29, 2017.		The 2013 Warrants have an exercise price of $2.91 per share and became exercisable on September 4, 2013 and expire on September 4, 2016.	The Agents Warrant became exercisable on September 4, 2013 and will expire on October 9, 2017.
Fair Value Of Warrant Issued				2,155,527		3,574,180	115,150
Fair Value Assumptions Fair Value				$ 1.58		$ 1.59	$ 1.88
Debt Instrument, Unamortized Discount				2,155,527
Debt Conversion, Converted Instrument, Amount					144,658
Debt Conversion, Converted Instrument, Shares Issued					8,821,431
Debt Instrument, Interest Rate, Stated Percentage				6.00%	6.00%
Debt Instrument, Convertible, Conversion Price					$ 1.15
Debt Instrument, Convertible, Beneficial Conversion Feature			7,057,153		7,057,153
Fair Value Assumptions, Expected Volatility Rate				103.00%		102.30%	111.90%
Debt Issuance Cost				683,955
Proceeds from Debt, Net of Issuance Costs				9,300,000
Net Proceeds From Issuance Of Common Stock						10,300,000
Market Value Of Common Stock								$ 9.46
Accumulated Unpaid Dividend									9,380,000
Accumulated Unpaid Dividend Per Share									$ 2.80
Preferred Stock, Dividend Rate, Percentage		6.00%
Stock Issued During Period, Shares, New Issues	4,495,828							3,350,000
Preferred Stock, Conversion Basis								The Series A Preferred Stock was convertible, at the option of Celgene, at any time, into common stock at an initial per common share conversion price of $11.00 (1 share of preferred converts into .45 shares of common).
Convertible Debt				$ 10,000,000